T44 — ICD-10-CM Diagnosis Codes

• T44 Poisoning by, adverse effect of and underdosing of drugs primarily affecting the autonomic nervous system
• T44.0 Poisoning by, adverse effect of and underdosing of anticholinesterase agents
• T44.0X Poisoning by, adverse effect of and underdosing of anticholinesterase agents
• T44.0X1 Poisoning by anticholinesterase agents, accidental (unintentional)
• T44.0X1A Poisoning by anticholinesterase agents, accidental (unintentional), initial encounter billable
• T44.0X1D Poisoning by anticholinesterase agents, accidental (unintentional), subsequent encounter billable
• T44.0X1S Poisoning by anticholinesterase agents, accidental (unintentional), sequela billable
• T44.0X2 Poisoning by anticholinesterase agents, intentional self-harm
• T44.0X2A Poisoning by anticholinesterase agents, intentional self-harm, initial encounter billable
• T44.0X2D Poisoning by anticholinesterase agents, intentional self-harm, subsequent encounter billable
• T44.0X2S Poisoning by anticholinesterase agents, intentional self-harm, sequela billable
• T44.0X3 Poisoning by anticholinesterase agents, assault
• T44.0X3A Poisoning by anticholinesterase agents, assault, initial encounter billable
• T44.0X3D Poisoning by anticholinesterase agents, assault, subsequent encounter billable
• T44.0X3S Poisoning by anticholinesterase agents, assault, sequela billable
• T44.0X4 Poisoning by anticholinesterase agents, undetermined
• T44.0X4A Poisoning by anticholinesterase agents, undetermined, initial encounter billable
• T44.0X4D Poisoning by anticholinesterase agents, undetermined, subsequent encounter billable
• T44.0X4S Poisoning by anticholinesterase agents, undetermined, sequela billable
• T44.0X5 Adverse effect of anticholinesterase agents
• T44.0X5A Adverse effect of anticholinesterase agents, initial encounter billable
• T44.0X5D Adverse effect of anticholinesterase agents, subsequent encounter billable
• T44.0X5S Adverse effect of anticholinesterase agents, sequela billable
• T44.0X6 Underdosing of anticholinesterase agents
• T44.0X6A Underdosing of anticholinesterase agents, initial encounter billable
• T44.0X6D Underdosing of anticholinesterase agents, subsequent encounter billable
• T44.0X6S Underdosing of anticholinesterase agents, sequela billable
• T44.1 Poisoning by, adverse effect of and underdosing of other parasympathomimetics [cholinergics]
• T44.1X Poisoning by, adverse effect of and underdosing of other parasympathomimetics [cholinergics]
• T44.1X1 Poisoning by other parasympathomimetics [cholinergics], accidental (unintentional)
• T44.1X1A Poisoning by other parasympathomimetics [cholinergics], accidental (unintentional), initial encounter billable
• T44.1X1D Poisoning by other parasympathomimetics [cholinergics], accidental (unintentional), subsequent encounter billable
• T44.1X1S Poisoning by other parasympathomimetics [cholinergics], accidental (unintentional), sequela billable
• T44.1X2 Poisoning by other parasympathomimetics [cholinergics], intentional self-harm
• T44.1X2A Poisoning by other parasympathomimetics [cholinergics], intentional self-harm, initial encounter billable
• T44.1X2D Poisoning by other parasympathomimetics [cholinergics], intentional self-harm, subsequent encounter billable
• T44.1X2S Poisoning by other parasympathomimetics [cholinergics], intentional self-harm, sequela billable
• T44.1X3 Poisoning by other parasympathomimetics [cholinergics], assault
• T44.1X3A Poisoning by other parasympathomimetics [cholinergics], assault, initial encounter billable
• T44.1X3D Poisoning by other parasympathomimetics [cholinergics], assault, subsequent encounter billable
• T44.1X3S Poisoning by other parasympathomimetics [cholinergics], assault, sequela billable
• T44.1X4 Poisoning by other parasympathomimetics [cholinergics], undetermined
• T44.1X4A Poisoning by other parasympathomimetics [cholinergics], undetermined, initial encounter billable
• T44.1X4D Poisoning by other parasympathomimetics [cholinergics], undetermined, subsequent encounter billable
• T44.1X4S Poisoning by other parasympathomimetics [cholinergics], undetermined, sequela billable
• T44.1X5 Adverse effect of other parasympathomimetics [cholinergics]
• T44.1X5A Adverse effect of other parasympathomimetics [cholinergics], initial encounter billable
• T44.1X5D Adverse effect of other parasympathomimetics [cholinergics], subsequent encounter billable
• T44.1X5S Adverse effect of other parasympathomimetics [cholinergics], sequela billable
• T44.1X6 Underdosing of other parasympathomimetics [cholinergics]
• T44.1X6A Underdosing of other parasympathomimetics [cholinergics], initial encounter billable
• T44.1X6D Underdosing of other parasympathomimetics [cholinergics], subsequent encounter billable
• T44.1X6S Underdosing of other parasympathomimetics [cholinergics], sequela billable
• T44.2 Poisoning by, adverse effect of and underdosing of ganglionic blocking drugs
• T44.2X Poisoning by, adverse effect of and underdosing of ganglionic blocking drugs
• T44.2X1 Poisoning by ganglionic blocking drugs, accidental (unintentional)
• T44.2X1A Poisoning by ganglionic blocking drugs, accidental (unintentional), initial encounter billable
• T44.2X1D Poisoning by ganglionic blocking drugs, accidental (unintentional), subsequent encounter billable
• T44.2X1S Poisoning by ganglionic blocking drugs, accidental (unintentional), sequela billable
• T44.2X2 Poisoning by ganglionic blocking drugs, intentional self-harm
• T44.2X2A Poisoning by ganglionic blocking drugs, intentional self-harm, initial encounter billable
• T44.2X2D Poisoning by ganglionic blocking drugs, intentional self-harm, subsequent encounter billable
• T44.2X2S Poisoning by ganglionic blocking drugs, intentional self-harm, sequela billable
• T44.2X3 Poisoning by ganglionic blocking drugs, assault
• T44.2X3A Poisoning by ganglionic blocking drugs, assault, initial encounter billable
• T44.2X3D Poisoning by ganglionic blocking drugs, assault, subsequent encounter billable
• T44.2X3S Poisoning by ganglionic blocking drugs, assault, sequela billable
• T44.2X4 Poisoning by ganglionic blocking drugs, undetermined
• T44.2X4A Poisoning by ganglionic blocking drugs, undetermined, initial encounter billable
• T44.2X4D Poisoning by ganglionic blocking drugs, undetermined, subsequent encounter billable
• T44.2X4S Poisoning by ganglionic blocking drugs, undetermined, sequela billable
• T44.2X5 Adverse effect of ganglionic blocking drugs
• T44.2X5A Adverse effect of ganglionic blocking drugs, initial encounter billable
• T44.2X5D Adverse effect of ganglionic blocking drugs, subsequent encounter billable
• T44.2X5S Adverse effect of ganglionic blocking drugs, sequela billable
• T44.2X6 Underdosing of ganglionic blocking drugs
• T44.2X6A Underdosing of ganglionic blocking drugs, initial encounter billable
• T44.2X6D Underdosing of ganglionic blocking drugs, subsequent encounter billable
• T44.2X6S Underdosing of ganglionic blocking drugs, sequela billable
• T44.3 Poisoning by, adverse effect of and underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics
• T44.3X Poisoning by, adverse effect of and underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics
• T44.3X1 Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional)
• T44.3X1A Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), initial encounter billable
• T44.3X1D Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), subsequent encounter billable
• T44.3X1S Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), sequela billable
• T44.3X2 Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm
• T44.3X2A Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, initial encounter billable
• T44.3X2D Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, subsequent encounter billable
• T44.3X2S Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, sequela billable
• T44.3X3 Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault
• T44.3X3A Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, initial encounter billable
• T44.3X3D Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, subsequent encounter billable
• T44.3X3S Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, sequela billable
• T44.3X4 Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined
• T44.3X4A Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, initial encounter billable
• T44.3X4D Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, subsequent encounter billable
• T44.3X4S Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, sequela billable
• T44.3X5 Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics
• T44.3X5A Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter billable
• T44.3X5D Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter billable
• T44.3X5S Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela billable
• T44.3X6 Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics
• T44.3X6A Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter billable
• T44.3X6D Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter billable
• T44.3X6S Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela billable
• T44.4 Poisoning by, adverse effect of and underdosing of predominantly alpha-adrenoreceptor agonists
• T44.4X Poisoning by, adverse effect of and underdosing of predominantly alpha-adrenoreceptor agonists
• T44.4X1 Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional)
• T44.4X1A Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), initial encounter billable
• T44.4X1D Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), subsequent encounter billable
• T44.4X1S Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), sequela billable
• T44.4X2 Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm
• T44.4X2A Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, initial encounter billable
• T44.4X2D Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, subsequent encounter billable
• T44.4X2S Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, sequela billable
• T44.4X3 Poisoning by predominantly alpha-adrenoreceptor agonists, assault
• T44.4X3A Poisoning by predominantly alpha-adrenoreceptor agonists, assault, initial encounter billable
• T44.4X3D Poisoning by predominantly alpha-adrenoreceptor agonists, assault, subsequent encounter billable
• T44.4X3S Poisoning by predominantly alpha-adrenoreceptor agonists, assault, sequela billable
• T44.4X4 Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined
• T44.4X4A Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, initial encounter billable
• T44.4X4D Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, subsequent encounter billable
• T44.4X4S Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, sequela billable
• T44.4X5 Adverse effect of predominantly alpha-adrenoreceptor agonists
• T44.4X5A Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter billable
• T44.4X5D Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter billable
• T44.4X5S Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela billable
• T44.4X6 Underdosing of predominantly alpha-adrenoreceptor agonists
• T44.4X6A Underdosing of predominantly alpha-adrenoreceptor agonists, initial encounter billable
• T44.4X6D Underdosing of predominantly alpha-adrenoreceptor agonists, subsequent encounter billable
• T44.4X6S Underdosing of predominantly alpha-adrenoreceptor agonists, sequela billable
• T44.5 Poisoning by, adverse effect of and underdosing of predominantly beta-adrenoreceptor agonists
• T44.5X Poisoning by, adverse effect of and underdosing of predominantly beta-adrenoreceptor agonists
• T44.5X1 Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional)
• T44.5X1A Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), initial encounter billable
• T44.5X1D Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), subsequent encounter billable
• T44.5X1S Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), sequela billable
• T44.5X2 Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm
• T44.5X2A Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, initial encounter billable
• T44.5X2D Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, subsequent encounter billable
• T44.5X2S Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, sequela billable
• T44.5X3 Poisoning by predominantly beta-adrenoreceptor agonists, assault
• T44.5X3A Poisoning by predominantly beta-adrenoreceptor agonists, assault, initial encounter billable
• T44.5X3D Poisoning by predominantly beta-adrenoreceptor agonists, assault, subsequent encounter billable
• T44.5X3S Poisoning by predominantly beta-adrenoreceptor agonists, assault, sequela billable
• T44.5X4 Poisoning by predominantly beta-adrenoreceptor agonists, undetermined
• T44.5X4A Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, initial encounter billable
• T44.5X4D Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, subsequent encounter billable
• T44.5X4S Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, sequela billable
• T44.5X5 Adverse effect of predominantly beta-adrenoreceptor agonists
• T44.5X5A Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter billable
• T44.5X5D Adverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter billable
• T44.5X5S Adverse effect of predominantly beta-adrenoreceptor agonists, sequela billable
• T44.5X6 Underdosing of predominantly beta-adrenoreceptor agonists
• T44.5X6A Underdosing of predominantly beta-adrenoreceptor agonists, initial encounter billable
• T44.5X6D Underdosing of predominantly beta-adrenoreceptor agonists, subsequent encounter billable
• T44.5X6S Underdosing of predominantly beta-adrenoreceptor agonists, sequela billable
• T44.6 Poisoning by, adverse effect of and underdosing of alpha-adrenoreceptor antagonists
• T44.6X Poisoning by, adverse effect of and underdosing of alpha-adrenoreceptor antagonists
• T44.6X1 Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional)
• T44.6X1A Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), initial encounter billable
• T44.6X1D Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), subsequent encounter billable
• T44.6X1S Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), sequela billable
• T44.6X2 Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm
• T44.6X2A Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, initial encounter billable
• T44.6X2D Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, subsequent encounter billable
• T44.6X2S Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, sequela billable
• T44.6X3 Poisoning by alpha-adrenoreceptor antagonists, assault
• T44.6X3A Poisoning by alpha-adrenoreceptor antagonists, assault, initial encounter billable
• T44.6X3D Poisoning by alpha-adrenoreceptor antagonists, assault, subsequent encounter billable
• T44.6X3S Poisoning by alpha-adrenoreceptor antagonists, assault, sequela billable
• T44.6X4 Poisoning by alpha-adrenoreceptor antagonists, undetermined
• T44.6X4A Poisoning by alpha-adrenoreceptor antagonists, undetermined, initial encounter billable
• T44.6X4D Poisoning by alpha-adrenoreceptor antagonists, undetermined, subsequent encounter billable
• T44.6X4S Poisoning by alpha-adrenoreceptor antagonists, undetermined, sequela billable
• T44.6X5 Adverse effect of alpha-adrenoreceptor antagonists
• T44.6X5A Adverse effect of alpha-adrenoreceptor antagonists, initial encounter billable
• T44.6X5D Adverse effect of alpha-adrenoreceptor antagonists, subsequent encounter billable
• T44.6X5S Adverse effect of alpha-adrenoreceptor antagonists, sequela billable
• T44.6X6 Underdosing of alpha-adrenoreceptor antagonists
• T44.6X6A Underdosing of alpha-adrenoreceptor antagonists, initial encounter billable
• T44.6X6D Underdosing of alpha-adrenoreceptor antagonists, subsequent encounter billable
• T44.6X6S Underdosing of alpha-adrenoreceptor antagonists, sequela billable
• T44.7 Poisoning by, adverse effect of and underdosing of beta-adrenoreceptor antagonists
• T44.7X Poisoning by, adverse effect of and underdosing of beta-adrenoreceptor antagonists
• T44.7X1 Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional)
• T44.7X1A Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional), initial encounter billable
• T44.7X1D Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional), subsequent encounter billable
• T44.7X1S Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional), sequela billable
• T44.7X2 Poisoning by beta-adrenoreceptor antagonists, intentional self-harm
• T44.7X2A Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, initial encounter billable
• T44.7X2D Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, subsequent encounter billable
• T44.7X2S Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, sequela billable
• T44.7X3 Poisoning by beta-adrenoreceptor antagonists, assault
• T44.7X3A Poisoning by beta-adrenoreceptor antagonists, assault, initial encounter billable
• T44.7X3D Poisoning by beta-adrenoreceptor antagonists, assault, subsequent encounter billable
• T44.7X3S Poisoning by beta-adrenoreceptor antagonists, assault, sequela billable
• T44.7X4 Poisoning by beta-adrenoreceptor antagonists, undetermined
• T44.7X4A Poisoning by beta-adrenoreceptor antagonists, undetermined, initial encounter billable
• T44.7X4D Poisoning by beta-adrenoreceptor antagonists, undetermined, subsequent encounter billable
• T44.7X4S Poisoning by beta-adrenoreceptor antagonists, undetermined, sequela billable
• T44.7X5 Adverse effect of beta-adrenoreceptor antagonists
• T44.7X5A Adverse effect of beta-adrenoreceptor antagonists, initial encounter billable
• T44.7X5D Adverse effect of beta-adrenoreceptor antagonists, subsequent encounter billable
• T44.7X5S Adverse effect of beta-adrenoreceptor antagonists, sequela billable
• T44.7X6 Underdosing of beta-adrenoreceptor antagonists
• T44.7X6A Underdosing of beta-adrenoreceptor antagonists, initial encounter billable
• T44.7X6D Underdosing of beta-adrenoreceptor antagonists, subsequent encounter billable
• T44.7X6S Underdosing of beta-adrenoreceptor antagonists, sequela billable
• T44.8 Poisoning by, adverse effect of and underdosing of centrally-acting and adrenergic-neuron- blocking agents
• T44.8X Poisoning by, adverse effect of and underdosing of centrally-acting and adrenergic- neuron-blocking agents
• T44.8X1 Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional)
• T44.8X1A Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), initial encounter billable
• T44.8X1D Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), subsequent encounter billable
• T44.8X1S Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), sequela billable
• T44.8X2 Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm
• T44.8X2A Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, initial encounter billable
• T44.8X2D Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, subsequent encounter billable
• T44.8X2S Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, sequela billable
• T44.8X3 Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault
• T44.8X3A Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, initial encounter billable
• T44.8X3D Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, subsequent encounter billable
• T44.8X3S Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, sequela billable
• T44.8X4 Poisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined
• T44.8X4A Poisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined, initial encounter billable
• T44.8X4D Poisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined, subsequent encounter billable
• T44.8X4S Poisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined, sequela billable
• T44.8X5 Adverse effect of centrally-acting and adrenergic-neuron-blocking agents
• T44.8X5A Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter billable
• T44.8X5D Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter billable
• T44.8X5S Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, sequela billable
• T44.8X6 Underdosing of centrally-acting and adrenergic-neuron-blocking agents
• T44.8X6A Underdosing of centrally-acting and adrenergic-neuron-blocking agents, initial encounter billable
• T44.8X6D Underdosing of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter billable
• T44.8X6S Underdosing of centrally-acting and adrenergic-neuron-blocking agents, sequela billable
• T44.9 Poisoning by, adverse effect of and underdosing of other and unspecified drugs primarily affecting the autonomic nervous system
• T44.90 Poisoning by, adverse effect of and underdosing of unspecified drugs primarily affecting the autonomic nervous system
• T44.901 Poisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional)
• T44.901A Poisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional), initial encounter billable
• T44.901D Poisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional), subsequent encounter billable
• T44.901S Poisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional), sequela billable
• T44.902 Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm
• T44.902A Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, initial encounter billable
• T44.902D Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, subsequent encounter billable
• T44.902S Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, sequela billable
• T44.903 Poisoning by unspecified drugs primarily affecting the autonomic nervous system, assault
• T44.903A Poisoning by unspecified drugs primarily affecting the autonomic nervous system, assault, initial encounter billable
• T44.903D Poisoning by unspecified drugs primarily affecting the autonomic nervous system, assault, subsequent encounter billable
• T44.903S Poisoning by unspecified drugs primarily affecting the autonomic nervous system, assault, sequela billable
• T44.904 Poisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined
• T44.904A Poisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, initial encounter billable
• T44.904D Poisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, subsequent encounter billable
• T44.904S Poisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, sequela billable
• T44.905 Adverse effect of unspecified drugs primarily affecting the autonomic nervous system
• T44.905A Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, initial encounter billable
• T44.905D Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter billable
• T44.905S Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, sequela billable
• T44.906 Underdosing of unspecified drugs primarily affecting the autonomic nervous system
• T44.906A Underdosing of unspecified drugs primarily affecting the autonomic nervous system, initial encounter billable
• T44.906D Underdosing of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter billable
• T44.906S Underdosing of unspecified drugs primarily affecting the autonomic nervous system, sequela billable
• T44.99 Poisoning by, adverse effect of and underdosing of other drugs primarily affecting the autonomic nervous system
• T44.991 Poisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional)
• T44.991A Poisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional), initial encounter billable
• T44.991D Poisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional), subsequent encounter billable
• T44.991S Poisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional), sequela billable
• T44.992 Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm
• T44.992A Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, initial encounter billable
• T44.992D Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, subsequent encounter billable
• T44.992S Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, sequela billable
• T44.993 Poisoning by other drug primarily affecting the autonomic nervous system, assault
• T44.993A Poisoning by other drug primarily affecting the autonomic nervous system, assault, initial encounter billable
• T44.993D Poisoning by other drug primarily affecting the autonomic nervous system, assault, subsequent encounter billable
• T44.993S Poisoning by other drug primarily affecting the autonomic nervous system, assault, sequela billable
• T44.994 Poisoning by other drug primarily affecting the autonomic nervous system, undetermined
• T44.994A Poisoning by other drug primarily affecting the autonomic nervous system, undetermined, initial encounter billable
• T44.994D Poisoning by other drug primarily affecting the autonomic nervous system, undetermined, subsequent encounter billable
• T44.994S Poisoning by other drug primarily affecting the autonomic nervous system, undetermined, sequela billable
• T44.995 Adverse effect of other drug primarily affecting the autonomic nervous system
• T44.995A Adverse effect of other drug primarily affecting the autonomic nervous system, initial encounter billable
• T44.995D Adverse effect of other drug primarily affecting the autonomic nervous system, subsequent encounter billable
• T44.995S Adverse effect of other drug primarily affecting the autonomic nervous system, sequela billable
• T44.996 Underdosing of other drug primarily affecting the autonomic nervous system
• T44.996A Underdosing of other drug primarily affecting the autonomic nervous system, initial encounter billable
• T44.996D Underdosing of other drug primarily affecting the autonomic nervous system, subsequent encounter billable
• T44.996S Underdosing of other drug primarily affecting the autonomic nervous system, sequela billable